4.7 Article

Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets

Zhangfeng Zhong et al.

Summary: Immunotherapy has great potential in cancer treatment, but there are challenges such as immunotoxicity, single-source antibodies, and single-targeting strategies. Natural compounds from herbal medicines have shown promise as lead compounds for cancer treatment. This study summarizes current medication for cancer immunotherapy and discusses the potential of herbal medicines as immune checkpoint inhibitors with broad immunomodulatory effects.

MEDICINAL RESEARCH REVIEWS (2022)

Article Plant Sciences

Anti-tumor activities of Panax quinquefolius saponins and potential biomarkers in prostate cancer

Shan He et al.

Summary: Panax quinquefolius saponins (PQS) exhibit anti-cancer activity in human prostate cancer cells by inhibiting proliferation and promoting apoptosis. TMEM79 and ACOXL may serve as novel biomarkers for prostate cancer diagnosis.

JOURNAL OF GINSENG RESEARCH (2021)

Article Oncology

Immunometabolic Interplay in the Tumor Microenvironment

Irem Kaymak et al.

Summary: The study discusses the metabolic characteristics of immune cells in the tumor microenvironment and proposes future research directions.

CANCER CELL (2021)

Review Oncology

NK cell-based cancer immunotherapy: from basic biology to clinical development

Sizhe Liu et al.

Summary: NK cells, as a specialized immune effector cell type, play a critical role in immune activation against abnormal cells. Unlike T cell activation, NK cell activation is governed by interactions between NK receptors and target cells, leading to significant attention in cancer immunotherapy. Many efforts are focused on developing and engineering NK cell-based cancer immunotherapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Pharmacology & Pharmacy

p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier

Li Yuan et al.

Summary: This study demonstrated that high expression of p-MEK may be an independent factor of poor prognosis in patients with AEG, and the traditional Chinese medicine Huaier exerts its anti-AEG efficacy by inhibiting the MEK/ERK signaling pathway both in vitro and in vivo.

PHARMACOLOGICAL RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis

Sascha D. Markowitsch et al.

Summary: Therapy resistance in advanced prostate carcinoma (PCa) leads to poor prognosis, necessitating new treatment options. Shikonin (SHI) has shown promising growth inhibition effects on both therapy-sensitive and DX-resistant PCa cell lines, primarily through induction of necroptosis.

CANCERS (2021)

Review Cell Biology

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy

Mithunah Krishnamoorthy et al.

Summary: Myeloid cells can transform into myeloid-derived suppressor cells during cancer progression or chronic inflammation, inhibiting anti-tumor immunity. Overcoming the suppression caused by MDSCs is a major obstacle in cancer immunotherapy, highlighting the importance of understanding the mechanisms behind how MDSCs promote tumor growth for improving and developing new therapies.

CELLS (2021)

Article Oncology

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

Ze-Bo Jiang et al.

Summary: The study showed that luteolin and apigenin can effectively inhibit the proliferation of KRAS-mutant lung cancer cells, reduce the expression of IFN-gamma-induced PD-L1, and induce apoptosis by suppressing STAT3 phosphorylation. Combined treatment with PD-1 blockade and apigenin/luteolin had a synergistic effect, offering a potential therapeutic strategy for NSCLC with KRAS mutations.

CANCER LETTERS (2021)

Review Oncology

Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization

Christopher Groth et al.

Summary: This review summarizes the origin of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) and their relation to classical neutrophils, outlining their metastasis promoting features and promising strategies for targeting them to enhance the efficacy of cancer immunotherapy.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer

Long Jiao et al.

Summary: mTOR pathway activation is common in cancer, but mTOR inhibitors have not shown significant antiproliferative efficacy in most cancer types. Research on mTOR inhibition in hepatocytes reveals that non-malignant host cells may contribute to resistance against mTOR inhibitors.

JOURNAL OF PATHOLOGY (2021)

Review Pharmacology & Pharmacy

Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy

Shan Wang et al.

Summary: Metabolic reprogramming is crucial in cancer progression, and traditional Chinese medicine (TCM) with its bioactive components has shown promise in targeting cancer cells' metabolic pathways. TCM exerts its anti-tumor effects by regulating multiple metabolic processes in cancer cells, offering a potential natural approach for developing anti-tumor drugs.

PHARMACOLOGICAL RESEARCH (2021)

Review Oncology

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

Suchit Jhunjhunwala et al.

Summary: This review discusses the importance of antigen presentation in the success of immune checkpoint inhibition therapy and mechanisms by which tumors evade immune recognition. Tumors evade immune recognition by modulating antigen expression and altering antigen presentation.

NATURE REVIEWS CANCER (2021)

Article Gastroenterology & Hepatology

A risk-scoring system to predict clinical failure for patients with achalasia after peroral endoscopic myotomy

Xin-Yang Liu et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Article Biochemistry & Molecular Biology

Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation

Wenfang Li et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Review Biochemistry & Molecular Biology

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance

Xinyi Zhang et al.

MOLECULAR CANCER (2020)

Article Pharmacology & Pharmacy

Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis

Junjie Yin et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism

Leila Sarah Sellam et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)

Review Cell Biology

The Roles of CD8(+) T Cell Subsets in Antitumor Immunity

Michael St Paul et al.

TRENDS IN CELL BIOLOGY (2020)

Review Cell Biology

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

Jing-Li Xu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Huaier n-butanol extract suppresses proliferation and metastasis of gastric cancer via c-Myc-Bmi1 axis

Yiping Wang et al.

SCIENTIFIC REPORTS (2019)

Review Immunology

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

Viktor Fleming et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes

Jingjing Zhu et al.

NATURE COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Abigail E. Overacre-Delgoffe et al.

Article Multidisciplinary Sciences

Huaier extract suppresses breast cancer via regulating tumor-associated macrophages

Yaming Li et al.

SCIENTIFIC REPORTS (2016)

Article Immunology

IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer

Kevin M. Hart et al.

FRONTIERS IN IMMUNOLOGY (2011)